• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • PRODUCT SECTIONS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • VIDEOS

What’s Happening with Globus Medical? Why Has the Stock Dropped So Much? Will It Recover?

May 9, 2025 By SPINEMarketGroup Leave a Comment

Globus Medical (NYSE: GMED) has experienced a significant drop in its stock price today, trading at $58.63 — a 19% decline today.

Why Has It Dropped So Much?

The drop in Globus Medical’s stock is due to several factors:

  • Rising Costs: In Q2 2024, the company saw a 240% increase in the cost of goods sold, driven by global inflation and rising raw material and shipping costs.
  • Higher Operating Expenses: Selling, general, and administrative (SG&A) expenses rose significantly due to increased staffing costs and other operational expenditures.
  • Competitive Market: The musculoskeletal device market is highly competitive, with companies like Medtronic, Stryker and many others applying pressure on margins.
  • Macroeconomic Factors: The company is also facing headwinds from financial market volatility and interest rate fluctuations, which impact profitability.

Will It Recover?

Despite these challenges, there are positive signs:

  • Strategic Merger: In September 2023, Globus Medical completed its merger with NuVasive, expanding its product portfolio and strengthening its global market position.
  • Revenue Growth: In Q1 2024, musculoskeletal revenue increased by 124.8%, driven by the merger and growth in spine and trauma segments.
  • Strong Financial Position: The company ended Q1 2024 with $434 million in cash and equivalents and no long-term debt.
  • Positive Outlook: Consensus estimates for 2024 project revenue of approximately $2.47 billion, representing a 57.8% increase year-over-year.
    Additionally, the company has raised its adjusted EPS guidance for 2024 to a range of $2.75 to $2.85, reflecting confidence in overcoming current challenges.

Final Thoughts

There’s no doubt that Globus Medical is facing a challenging moment — the sharp drop in stock price reflects investor concern over rising costs, integration complexities following the NuVasive merger, and macroeconomic headwinds. However, when we take a step back and look at the bigger picture, there are strong reasons to remain hopeful about the company’s future.

The merger with NuVasive, completed in late 2023, is more than just an acquisition — it’s a transformational move that positions Globus as one of the top global players in musculoskeletal and spine solutions. The combined product portfolio, expanded global footprint, and complementary strengths are expected to deliver significant value over the medium to long term.

Importantly, the company’s leadership has reaffirmed its confidence in this strategy. For the full year 2024, Globus has raised its guidance, now projecting:

  • Revenue of approximately $2.47 billion — a year-over-year increase of nearly 58%, driven by continued growth in the spine, trauma, and enabling technologies segments.
  • Adjusted EPS between $2.75 and $2.85, reflecting not only revenue growth but also improving cost controls and operational synergies from the merger.

Analysts are also beginning to take a more constructive view. Several equity research firms have maintained a “Buy” or “Outperform” rating, highlighting the company’s strong cash position, absence of long-term debt, and the strategic logic behind the merger. Most forecasts suggest that once the post-merger integration stabilizes — likely in the second half of 2025 — Globus could enter a new phase of sustained growth and margin improvement.

###

(Visited 2 times, 2 visits today)

Filed Under: NEWS Tagged With: 2025

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

PLATINUM SPONSORS

GOLD SPONSORS

MOST POPULAR POSTS

  • BROCHURES
  • Stryker’s Spine Business Sale: A Smart Move or a…
  • Stryker’s Spine Exit: What It Means for…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • (UPDATED 2024): +8 Lumbar Artificial Discs to Know…
  • What Are the Strategic Reasons Behind Globus…
  • Why Didn’t Globus Medical’s Stock Rise After…
  • Update:Stay Tuned Next Week! Is Globus Medical the…
  • Globus Medical extends versatility of Advanced…
  • M6 Discontinued: What Are the Alternatives for a…
  • Dispute Over Spinal Implant Royalties Between…
  • (Updated!) 15 Expandable PLIF Cages to Know…!
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Alphatec Today: Where It Stands and Where It’s Heading?
  • (UPDATED 2024): +108 Stand-Alone Cervical Cages to Know..!
  • Eminent Spine’s 3D Printed Titanium Pedicle Screw…
  • Has Globus Already Surpassed Medtronic in the Spine…
  • Johnson & Johnson MedTech Secures Exclusive…
  • Sunday Reflections on the Changes in the Spine Market!
  • Viscogliosi Brothers Completes Acquisition of U.S.…
  • LAST 10 VIDEOS PUBLISHED

    1. POWEHI MEDICAL AG: TANTO® Screw
    2. Syntropiq: Taurus TLIF (Short)
    3. LEM Surgical: Dynamis Surgical Robot
    4. Aegis Spine:PathLoc-TA
    5. NGMedical: MOVE®-C Artificial Disc
    6. B.Braun Aesculap: Ennovate® Cervical MIS
    7. Spineart: PERLA® TL Deformity Solutions
    8. NGMedical: MOVE®-C
    9. Normmed Medical: ALIF Peek Cage
    10. PainTEQ: LinQ Sacroiliac

    Recent Comments

    • SPINEMarketGroup on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Sergio López-Fombona on M6 Discontinued: What Are the Alternatives for a Cervical Artificial Disc?
    • Drew on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Ahmed Hassan El-Naggary on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Anonymous on Has Globus Already Surpassed Medtronic in the Spine Market? Can J&J Find Its Way Back to the Top?
    • Mid-career Xennnial on Is Being a Doctor a Job, or a Calling? The Generational Divide Reshaping Medicine
    • Email
    • Twitter
    • YouTube

    Subscribe to Our Newsletter!

    Check your inbox or spam folder to confirm your subscription.

    Footer

    • Email
    • Twitter
    • YouTube

    Contact us:

    [email protected] [email protected]

    PRIVATE POLICY

    • Legal Advice
    • Embed Link
    • VIDEOS

    Copyright © 2025 · SPINEMarketGroup

    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}